Selected Grants
Endocrinology and Metabolism Training Program
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2024 - 2029Identification of Host-Specific Determinants of APOL1-associated COVAN
ResearchAdvisor · Awarded by National Institutes of Health · 2024 - 2029TRIO NRSA Training Core-Pre Doc Trainee
Inst. Training Prgm or CMEPreceptor · Awarded by University of North Carolina - Chapel Hill · 2023 - 2028U2C/TL1 NC KUH TRIO Administrative Core
ResearchPreceptor · Awarded by University of North Carolina - Chapel Hill · 2023 - 2028Tissue-Specific Regulation and Effects of CYP24A1
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2027Novel Mechanisms and Therapeutic Targets for Pulmonary Hypertension in End-Stage Renal Disease (K23)
ResearchMentor · Awarded by National Institutes of Health · 2021 - 2026JAK-STAT Inhibition to Reduce Racial Disparities in Kidney Disease
ResearchCo Investigator · Awarded by National Institute on Minority Health and Health Disparities · 2021 - 2026Novel mechanisms underlying improved ischemic tolerance of female kidneys
ResearchCo-Sponsor · Awarded by American Heart Association · 2024 - 2025Protecting Kidney and Cardiovascular Health long after Kidney Transplant
ResearchPrincipal Investigator · Awarded by Boehringer Ingelheim Pharmaceuticals, Inc. · 2022 - 2025Diet and Hypertension Management in Chronic Kidney Disease
ResearchAdvisor · Awarded by National Institutes of Health · 2019 - 2025"HiLo": Pragmatic trial of higher vs. lower serum phosphate targets in patients undergoing hemodialysis
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2018 - 2025Metabolic regulation of pancreatitis
ResearchCo Investigator · Awarded by National Institutes of Health · 2020 - 2025Duke CTSA (TL1) Year 5
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2018 - 2024POSIBIL6 - Phase III
Clinical TrialPrincipal Investigator · Awarded by CSL Behring LLC · 2024 - 2024A phase 2b/3 Randomized Clinical Trial of Clazakizumab in Patients with End Stage Kidney Disease Undergoing Dialysis
Clinical TrialPrincipal Investigator · Awarded by CSL Behring LLC · 2022 - 2024The Role of Klotho and Serotonin in Cardiovascular Outcomes and Mortality in CKD
ResearchPrincipal Investigator · Awarded by University of Pennsylvania · 2021 - 2024Postdoctoral Training in Genomic Medicine Research
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2017 - 2023Duke Training Grant in Nephrology
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 1995 - 2023Targeting anti-ferroptotic pathways to prevent the AKI-to-CKD transition
FellowshipPrincipal Investigator · Awarded by American Heart Association · 2020 - 2021Harnessing Antioxidative Stress Pathways in Renal Epithelial Progenitors to Prevent AKI-to-CKD Transition
ResearchMentor · Awarded by ASN Foundation for Kidney Research · 2019 - 2020Pencast Videos to Boost Learning and Interest in Nephrology Among Internal Medicine Residents
ResearchMentor · Awarded by American Society of Nephrology · 2017 - 2020Molecular Mechanisms of Cardiac Injury Induced by FGF23 in the Settings of High Phosphate Diet and CKD
ResearchPrincipal Investigator · Awarded by Northwestern University · 2016 - 2020Phosphate and FGF23: Dietary and Molecular Mediators of Health Disparities in Cardiovasular and Kidney Diseases (Center)
ResearchPrincipal Investigator · Awarded by Northwestern University · 2016 - 2020Role of FGF23 in Mineral Metabolism Across the Spectrum of Chronic Kidney Disease
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2013 - 2019FGF23 and Cardiovascular Disease in CKD (CRIC)
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2013 - 2019Pilot Studies Targeting Mineral Metabolism in CKD
ResearchPrincipal Investigator · Awarded by Northwestern University · 2013 - 2019Impact of phosphate and FGF23 reduction on intermediate end points in CKD
ResearchPrincipal Investigator · Awarded by Northwestern University · 2017 - 2019Vitamin D Catabolism in Chronic Kidney Disease
ResearchPrincipal Investigator · Awarded by University of Washington · 2016 - 2019FGF-23 and Clinical outcomes in ADPKD
ResearchPrincipal Investigator · Awarded by University of Colorado - Denver · 2016 - 2018Mentored Patient-Oriented Research in Mineral Metabolism
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2012 - 2017External Relationships
- Akebia
- Alexion Pharmaceuticals, Inc. a subsidiary of AstraZeneca
- Enyo
- Jnana
- Pharmacosmos
- Torii
- Unicycive
- Walden Biosciences
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.